Seongnam, South Korea biotechnology company developing drug delivery formulations and therapeutic products.
Oscotec Inc., founded in 1988 and headquartered in Seongnam, South Korea, develops drug delivery systems and therapeutic products, with formulation technologies aimed at improving drug efficacy and bioavailability. Its partners include pharmaceutical companies and research institutions in North America and Europe. In December 2019 it raised KRW 22 billion in a PIPE transaction led by E&Investment, to fund Phase 2a rheumatoid arthritis and Phase 1a acute myelogenous leukemia treatment trials.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in